Mark Walzer results 1
· Newest (Page 1/1, per page 25)
Author: Mark Walzer ×Clear All Filters
Search Results
A randomized phase 1 single-dose polysomnography study of ASP8062, a GABAB receptor positive allosteric modulatorNARA Subscribed
Rationale Previous research suggests that sleep polysomnography and EEG endpoints can be used to assess GABAergic activity; however, the impact of GABA B receptor positive allosteric modulators on sleep endpoints remains unclear. Objectives This phase 1 study compared a single dose of ASP8062 (35 mg or 70 mg), a GABA B receptor positive allosteric modulator, with placebo and paroxetine (40 mg). Methods Healthy adult volunteers...
Previous1Next